K784-8023 Screening compound: N~1~-cyclopentyl-3-{[(4-ethylanilino)carbonyl]amino}-4-(6-oxo-7,11-diazatricyclo[7.3.1.0~2,7~]trideca-2,4-dien-11-yl)benzamide

K784-8023 Screening compound: N~1~-cyclopentyl-3-{[(4-ethylanilino)carbonyl]amino}-4-(6-oxo-7,11-diazatricyclo[7.3.1.0~2,7~]trideca-2,4-dien-11-yl)benzamide
K784-8023 Screening compound: N~1~-cyclopentyl-3-{[(4-ethylanilino)carbonyl]amino}-4-(6-oxo-7,11-diazatricyclo[7.3.1.0~2,7~]trideca-2,4-dien-11-yl)benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound K784-8023
N~1~-cyclopentyl-3-{[(4-ethylanilino)carbonyl]amino}-4-(6-oxo-7,11-diazatricyclo[7.3.1.0~2,7~]trideca-2,4-dien-11-yl)benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

K784-8023

Molecular Formula

C32H37N5O3 (C32 H37 N5 O3)

Compound Name

N~1~-cyclopentyl-3-{[(4-ethylanilino)carbonyl]amino}-4-(6-oxo-7,11-diazatricyclo[7.3.1.0~2,7~]trideca-2,4-dien-11-yl)benzamide

IUPAC name

N-cyclopentyl-3-{[(4-ethylphenyl)carbamoyl]amino}-4-{6-oxo-711-diazatricyclo[7.3.1.0^{27}]trideca-24-dien-11-yl}benzamide

SMILES

CCc(cc1)ccc1NC(Nc(cc(cc1)C(NC2CCCC2)=O)c1N(CC(C1)CN23)CC1C3=CC=CC2=O)=O

InChI

InChI=1S/C32H37N5O3/c1-2-21-10-13-26(14-11-21)34-32(40)35-27-17-23(31(39)33-25-6-3-4-7-25)12-15-29(27)36-18-22-16-24(20-36)28-8-5-9-30(38)37(28)19-22/h5,8-15,17,22,24-25H,2-4,6-7,16,18-20H2,1H3,(H,33,39)(H2,34,35,40)

InChI Key

RNMVLXGQMOIZHO-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15099118

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

539.68

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

3.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

6.170

Distribution Coefficient, logD

6.169

Water Solubility, LogSw

-5.45

Polar Surface Area

75.199

Acid Dissociation Constant (pKa)

10.13

Base Dissociation Constant (pKb)

6.78

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

40.60

K784-8023 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

CNS Targets (44014 compounds)

Lipid Metabolism Library (9174 compounds)

Protein-Protein Interaction Library (218420 compounds)

Spiro Library (21655 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Nervous system
  • Cardiovascular
  • Metabolic
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds
  • Cyclic compounds

References: we are preparing a list of scientific research reports with K784-8023 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound K784-8023?
Check Price and Availability of K784-8023, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of K784-8023 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for K784-8023
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for K784-8023
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of K784-8023 available by request